Pink SheetThe European Medicines Agency is this week set to decide whether to recommend granting pan-EU marketing authorization for six orphan drugs, including delandistrogene moxeparvovec, Roche/Sarepta Therap
Pink SheetGilead Sciences could learn this week whether the European Medicines Agency will recommend that lenacapavir should be approved for marketing as a twice-yearly preventative option for HIV in the EU as
In VivoImagine a patient with major depression who has tried three different antidepressants without success. Instead of guessing which medication to try next, their psychiatrist attaches a single EEG electr
ScripA few months after restructuring to conserve cash and put primary focus on its lead candidate BDTX-1535 in first-line non-small cell lung cancer, Black Diamond Therapeutics found a lifeline in Servier